Neoplasia/BPH

	The clinical application of Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR) in histologically confirmed prostate cancer recurrence after radical radiotherapy. Br J Radiol Rembak-Szynkiewicz J, Hebda A, Mazgaj P, Cortez AJ, Dyczkowski S, Kujawa K, Ko, Skrobisz K, Gabry. PMID: 41212262 [PubMed - as supplied by publisher]
	The Value of Intratumoral and Peritumoral Radiomics Based on Contrast-Enhanced Ultrasound for Predicting WHO/ISUP Grading of Clear Cell Renal Cell Carcinoma. J Ultrasound Med Chen Y, Zhuang J, Fu F, Lin P, Zheng W, Lian G, Zhu Y, Zhang H, Fan X, Ye Q. PMID: 41211801 [PubMed - as supplied by publisher]
	Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer. Prostate Lorenzo-Sánchez MV, Giménez-Bachs JM, Picazo-Martínez MG, Donate-Moreno MJ, Martínez-Sánchiz C, Tárraga-Honrubia MA, Navarro-Jiménez S, Legido-Gómez Ó, Salinas-Sánchez AS. PMID: 41211651 [PubMed - as supplied by publisher]
	A Prospective First-In-Human Pilot Study (18)F-DCFPyL Prostate-Specific Membrane Antigen Imaging on the RefleXion X1 Positron Emission Tomography-Computed Tomograpghy Subsystem in Patients with Prostate Cancer. Adv Radiat Oncol Liu B, Dandapani S, Li Y, Glaser S, Chen H, Dorff T, Yamauchi D, Chen Q, Qing K, Shi C, Da Silva AJ, Al Feghali KA, Liu A, Williams T, Wong JYC. PMID: 41211608 [PubMed - in process]
	Prognostic value of the systemic immune-inflammation index in bladder cancer: an update evidence-based analysis. Front Oncol Bai J, Huang Y, Chen B, Ran B, Jian S, Li J, Chen J, Wei Q, Cao D, Liu L. PMID: 41211449 [PubMed - in process]
	Artificial Intelligence Across the Prostate Cancer Pathway: Screening, Imaging, Pathology, and Biomarkers. Cureus Hasan MR, Ibraheem N, Rahman ME, Tamanna R. PMID: 41211255 [PubMed - in process]
	Ferroptosis research based on bibliometric and visual analysis: mechanism exploration and clinical application prospects in gastric cancer, prostate cancer, leukemia, and brain tumors. Front Med (Lausanne) Yu M, Cui W, Hu Y, Song W, Wang Z, Chen W, Ji X, Tang C, Lv J, Hao T. PMID: 41210865 [PubMed - in process]
	Local Genetic Correlations and Pleiotropy Reveal Shared Genetic Architecture Between COVID-19 Phenotypes and Prostate Cancer in European Populations. J Cancer Xiang R, Zhao X, Chen L, Wu X, Xiao J, Jiang X. PMID: 41210689 [PubMed - in process]
	Integrative Analysis of GEO Datasets and Mendelian Randomization Reveals a Potential Role ofISOC1 in Renal Cell Carcinoma. J Cancer Wang J, Liu Y, Yan Z, Lu Q, Jian J, Liu X, Chen Z, Zheng Q, Wan S, Wang L. PMID: 41210684 [PubMed - in process]
	Design of debunking the frailty-sarcopenia-ADT axis in metastatic prostate cancer with multicomponent exercise: the FIERCE trial protocol. Front Sports Act Living Wilson RL, Vulczak A, Morgans AK, Norris M, Greer J, Votta J, Vamvini M, Einstein DJ, Uno H, Rosenthal M, Vander Heiden MG, Dieli-Conwright CM. PMID: 41210271 [PubMed - in process]
	Comment on "Examining the role of elective pelvic radiotherapy in patients Diagnosed with high- and very High-Risk Non-Metastatic prostate cancer". Clin Transl Radiat Oncol Guan Y, Lu Y, Zhang G. PMID: 41210216 [PubMed - in process]
	Assessment of Online Adaptive MRI-Guided Stereotactic Body Radiotherapy (SBRT) With an Integrated Boost to the Dominant Lesion in Prostate Cancer. Cureus Padgett KR, Cabrera J, Sensoy L, Jin W, Abramowitz MC, Studenski M, Guerrero H, de la Zerda A, Nejad-Davarani SP, Ford JC, Dogan N. PMID: 41209871 [PubMed - in process]
	Microultrasound imaging for accuracy of diagnosis in prostate cancer: a singleâ€‘center observational study. Wideochir Inne Tech Maloinwazyjne Grynkiewicz M, Buffi NM, Fasulo V, Carne F, Beatrici E, Frego N, Wiewiora M, Lughezzani G. PMID: 41209759 [PubMed - in process]
	Risk-based screening and prognostic analysis for second primary malignancies in kidney cancer patients: a retrospective cohort study based on large-scale population and Mendelian randomization analysis. Int J Med Sci Zou M, Deng R, Liu H, Qiu J, Tian P, Shang J, Zhou J, Li X, Cai L, Wang Y, Gong K. PMID: 41209561 [PubMed - in process]
	Insomnia Proven to be Associated With Prostate Cancer: A Genetic Correlation Study Incorporating Lifestyle Factors. Alpha Psychiatry Chen X, Xie L, Liu X. PMID: 41209499 [PubMed - in process]
	Tabular prior-data fitted network in real-world CT radiomics: benign vs. malignant renal tumor classification. Quant Imaging Med Surg Liu T, Wang H, Guo Y, Ye Y, Weng B, Li X, Chen J, Xie S, Zhong G, Song Z, Huang L. PMID: 41209261 [PubMed - in process]
	CT radiomics for predicting postoperative disease specific survival in clear cell renal cell carcinoma: a multi-center study. Quant Imaging Med Surg Li W, Xie X, Li P, Zhu J, Li K, Jiang K, Zeng X, Liu H, Pei Y, Zhang Y, Zhang T, Wang R. PMID: 41209213 [PubMed - in process]
	The potential of (177Lu)-PSMA-617 in the first-line combination therapy with enzalutamide for metastatic castration-resistant prostate cancer: clinical insights from the ENZA-p trial. Chin Clin Oncol Zheng R, Freedland SJ, Nguyen AT. PMID: 41208428 [PubMed - in process]
	Unveiling prognostic biomarkers and immunotherapeutic insights in prostate cancer through multi-omics and machine learning. Eur J Med Res Tang H, Zhang W, Tao J, Zhang Y, Xing F, Wang Y, Yan Z, Gao Y, Zhang Z. PMID: 41207909 [PubMed - in process]
	Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial. Eur Urol Oncol Agrawal R, Weiner AB, Livingstone J, Pooli A, Huang RR, Ye H, Sisk A, Elashoff DA, Boutros PC, Rettig MB, Reiter RE. PMID: 41207813 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180860

Page 1 of 9043



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy